Треосульфан медак Uses, Dosage, Side Effects and more
Треосульфан медак is under investigation in Allogeneic Haematopoietic Stem Cell Transplantation. Треосульфан медак has been investigated for the treatment of Lymphoblastic Leukemia, Acute, Childhood.
Attribute | Details |
---|---|
Trade Name | Треосульфан медак |
Generic | Treosulfan |
Treosulfan Other Names | DIHYDROXYBUSULFAN, OVASTAT, Treosulfan |
Type | |
Formula | C6H14O8S2 |
Weight | Average: 278.29 Monoisotopic: 278.013009759 |
Groups | Approved, Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | Russia |
Last Updated: | January 7, 2025 at 1:49 am |